system to help fight cancer Working with your immune

Size: px
Start display at page:

Download "system to help fight cancer Working with your immune"

Transcription

1 KEYTRUDA Working with your immune system to help fight cancer

2 CONTACT DETAILS Your Oncologist/Specialist ABOUT About KEYTRUDA How KEYTRUDA works Name How KEYTRUDA works with your immune system Phone Phone (after hours) START How KEYTRUDA is given Effects on fertility Working during treatment Your Specialist Nurse Name MONITOR KEYTRUDA treatment experience Side effects may occur while taking KEYTRUDA Common side effects Phone Immune side effects Phone (after hours) MANAGE Managing side effects Be involved with your KEYTRUDA treatment Your Treatment Centre Name NOTES More information Notes for my next appointment Phone Phone (after hours)

3 About KEYTRUDA KEYTRUDA is a prescription medicine used to treat a number of cancers: Melanoma* A sub-type of lung cancer called non-small cell lung cancer (NSCLC)** A blood cancer called Hodgkin s lymphoma** A bladder cancer called Urothelial carcinoma.** KEYTRUDA is also currently being trialled in a number of new cancer types. KEYTRUDA works with the immune system to help find and destroy cancer cells. Talk to your doctor to see if KEYTRUDA is right for you. Use strictly as directed. If you have side effects, see your Doctor, Pharmacist or Healthcare Professional. KEYTRUDA contains the active substance pembrolizumab. *KEYTRUDA is fully funded under special authority criteria for people with advanced stage 3-4 melanoma that has spread and cannot be removed by surgery. **KEYTRUDA is registered for the treatment of NSCLC, Hodgkin s lymphoma and Urothelial Carcinoma, is not currently funded but is available privately. Funding applications have been sent to PHARMAC for both NSCLC and Hodgkin s lymphoma.

4 How KEYTRUDA works How KEYTRUDA works with your immune system KEYTRUDA is known as immuno-oncology (or immunotherapy) because it works with the body s immune system to help find and destroy cancer cells. KEYTRUDA helps the immune system do what it is designed to do; help detect and fight disease. KEYTRUDA is not chemotherapy. Chemotherapy involves the use of medicines to kill or slow the growth of cancer cells. The immune system is the body s natural defence against disease. It sends types of cells called T cells through the body to find and fight infections and diseases - including cancer. Some cancer cells grow by hiding from the immune system. Immuno-oncology drugs like KEYTRUDA work with the immune system to help find and fight certain cancer cells. Cancer cells may use PD-1 pathway to hide from T cells KEYTRUDA blocks PD-1 pathway to help prevent cancer cells from hiding T cells help detect and fight cancer cells immune system cancer cells KEYTRUDA The immune system finds and fights cancer cells as they grow, before they form tumours. The immune system destroys some cancer cells, but other cancer cells may hide from the immune system. These hiding cancer cells can then grow into tumours. KEYTRUDA helps the immune system find and treat cancer cells.

5 START KEYTRUDA HAS BEEN PRESCRIBED FOR YOU TO TREAT A TYPE OF CANCER. START

6 How KEYTRUDA is given Considerations before treatment KEYTRUDA is given by an injection via a vein in your arm (intravenous infusion) over 30 minutes. KEYTRUDA is usually given once every 3 weeks, often referred to as cycles. Your treatment will usually be given by your Oncologist/Specialist or Nurse in a hospital clinic. Your Oncologist/Specialist will decide how many treatments/cycles you need. It is not known if KEYTRUDA has effects on fertility and there is currently no information on its use in pregnant or breastfeeding women. Your Oncologist/Specialist will discuss the risks and benefits of treatment with you. Other considerations Your Oncologist/Specialist will review your general health, such as your age, liver and kidney function prior to treatment. Working during treatment It may be possible for you to continue working during treatment with KEYTRUDA, but you may not be able to maintain your usual work commitments because of your condition or side effects associated with therapy. Intravenous infusion Over 30 minutes Once every 3 weeks Talk with your Nurse, Healthcare Professional or the Cancer Society (contact details at the end of brochure) for advice on talking to your employer about your condition and ability to work.

7 MONITOR DURING YOUR TREATMENT WITH KEYTRUDA, THERE WILL BE REGULAR APPOINTMENTS TO MONITOR YOUR HEALTH AND ANY SIDE EFFECTS. MONITOR

8 KEYTRUDA treatment experience Side effects may occur while taking KEYTRUDA Before starting KEYTRUDA, your Oncologist/Specialist and Nurse would have asked you about your general health and any other medical problems. Medical tests that you may need during your treatment with KEYTRUDA may include: During your treatment with KEYTRUDA, there will be regular appointments to monitor your health and any side effects. KEYTRUDA can cause your immune system to affect healthy cells in other parts of your body. These side effects can sometimes become serious. It is important side effects are treated as early as possible. Scans X-rays Blood Tests These tests will help your Oncologist/Specialist keep track of how you are responding to treatment. Tell your Oncologist/Specialist if you notice any side effects or symptoms. Early treatment of side effects may stop them becoming more serious. You may be able to continue KEYTRUDA treatment if side effects are treated early. However, you may need to stop KEYTRUDA treatment if side effects become more serious.

9 Common side effects Immune side effects Pituitary gland Thyroid gland Report any side effects to your Oncologist/Specialist or Nurse immediately. They will advise you on the best management approach. These are the most common side effects that you may notice while taking KEYTRUDA. Common side effects that occurred in more than 1 in 10 people during KEYTRUDA clinical trials included: Feeling tired Itching Rash Nausea Diarrhoea Joint Pain As KEYTRUDA works with the immune system, there are specific side effects that may result from its action on the immune system. It is important to watch for these immune side effects so they can be treated quickly. This may allow you to continue with KEYTRUDA treatment. Lungs Liver Small intestine Adrenal glands Large intestine For other side effects that affected less than 1 in 10 people speak to your Oncologist/Specialist or Nurse, or refer to the Consumer Medicine Information for KEYTRUDA. Consumer Medicine Information (CMI) is available on request from your Oncologist/Specialist or Nurse or at medsafe.govt.nz/consumers/cmi/k/keytruda.pdf You may not have to stop KEYTRUDA treatment if your side effects are manageable. The next section guides you through possible immune side effects. Your Oncologist/Specialist or Nurse will decide how to manage these side effects. KEYTRUDA treatment may be delayed or stopped if these side effects are severe. Immune side effects can occur in the highlighted areas.

10 MANAGE BE INVOLVED WITH YOUR TREATMENT AND DISCUSS ANY SIDE EFFECTS WITH YOUR ONCOLOGIST/SPECIALIST OR NURSE SO THEY CAN BE TREATED QUICKLY. MANAGE

11 Managing side effects Call or see your Oncologist/Specialist or Nurse right away if you develop any symptoms of the following side effects. They will advise you on the best way to manage any side effects. Signs and symptoms of lung problems shortness of breath chest pain coughing Signs and symptoms of problems with your intestines diarrhoea or more bowel movements than usual your stools are black, tarry, sticky or have blood or mucus severe stomach pain or tenderness Signs and symptoms of hormone gland problems (especially the thyroid, pituitary, and adrenal glands) rapid heart beat weight loss increased sweating weight gain hair loss feeling cold constipation your voice gets deeper muscle aches dizziness or fainting headaches that will not go away or unusual headache Signs and symptoms of problems in other organs muscle pain or weakness changes in eyesight stomach area pain with nausea and vomiting (pancreatitis) shortness of breath, irregular heartbeat, feeling tired, or chest pain (myocarditis) Signs and symptoms of kidney problems changes in the amount or colour of your urine Signs and symptoms of skin problems rash itching skin blistering, peeling or sores ulcers in mouth or in lining of nose, throat, or genital area Signs and symptoms of liver problems nausea or vomiting feeling less hungry pain on the right side of your stomach your skin looks yellow the whites of your eyes look yellow dark urine you bleed or bruise more easily than normal Signs and symptoms of infusion (IV) reactions shortness of breath itching or rash dizziness fever Signs and symptoms of blood sugar problems feeling more hungry or thirsty needing to urinate more often weight loss

12 Be involved with your KEYTRUDA treatment Your regular appointments with your treatment team (eg. Oncologist/Specialist, Nurse, Pharmacist, Dietician, Physiotherapist) will allow you to get to know them. It is also important to stay in contact with your Oncologist/Specialist and Nurse if you experience any side effects during treatment. Call your clinic or get medical treatment right away. This may help to prevent them from becoming more serious. If you miss any appointments, call your Oncologist/Specialist or Nurse as soon as possible to make a new appointment. Tell other Healthcare Professionals, such as your Doctors, Dentists and Pharmacists that you are being treated with KEYTRUDA. If you plan to start on any new medicine, including those available without a prescription, tell your Doctor, Dentist or Pharmacist that you are being treated with KEYTRUDA.

13 More information If you have more questions about KEYTRUDA, other parts of your treatment or your condition, please talk to your Oncologist/Specialist or Nurse, refer to the Consumer Medicine Information (CMI) at or visit Cancer Society Tel: 0800 CANCER/ Lung Foundation New Zealand Tel: (+64) Melanoma New Zealand Tel: MSD Merck Sharp & Dohme (NZ) Limited Level 3, 123 Carlton Gore Road, Newmarket, Auckland 1023 Tel: Customer Services

14 Notes for my next appointment DATE DATE DATE DATE My notes: My notes: My notes: My notes: Questions to ask my Oncologist/Specialist: Questions to ask my Oncologist/Specialist: Questions to ask my Oncologist/Specialist: Questions to ask my Oncologist/Specialist:

15 References Consumer Medicine Information for KEYTRUDA. KEYTRUDA Data Sheet. KEYTRUDA (pembrolizumab) 50mg powder for infusion KEYTRUDA is a Prescription Only Medicine Use: KEYTRUDA is used in the treatment of melanoma which cannot be removed by surgery alone or when it has spread to multiple sites in the body. In the treatment of a kind of lung cancer called non-small cell lung cancer (NSCLC). In the treatment of classical Hodgkin Lymphoma (chl). In the treatment of urothelial carcinoma, including bladder cancer. Side effects: Immune-mediated side effects including inflammation of the lungs, colon, liver, kidneys, pituitary gland, brain, eye, muscles, nervous system, pancreas, and heart, thyroid disorders, type 1 diabetes mellitus. Severe skin reactions including Steven-Johnson syndrome and toxic epidermal necrolysis. Severe infusion reactions including hypersensitivity and anaphylaxis. Transplant recipients: rejection of a transplanted organ, graft-versus-host-disease (in people with a bone marrow transplant using donor cells). Very common side effects include diarrhea, nausea, itching, rash, joint pain, back pain, feeling tired, cough, patches of discoloured skin, stomach pain, decreased levels of sodium in blood. Tiredness, nausea, vomiting, diarrhea, constipation, shortness of breath, rash, itching, headache, hair loss, and, infections of the upper respiratory tract were reported when given in combination with chemotherapy. You may experience more than one side effect at the same time. All medicines have risks and benefits. Talk to your doctor to see if KEYTRUDA is right for you. KEYTRUDA is a funded medicine for melanoma patients restrictions apply. KEYTRUDA is an unfunded medicine for NSCLC, chl and urothelial carcinoma patients. Ask your health professional the cost of the medicine and any other medical fees that may apply. Use only as directed and if symptoms continue or you have side effects, see your doctor, pharmacist, or health professional. Based on data sheet prepared 16 October Marketed by: Merck Sharp & Dohme (New Zealand) Limited, Newmarket, Auckland. For additional product information, consult the Consumer Medicine Information (CMI), available on request, phone or refer to the Medsafe website Copyright 2018 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved. Copyright 2018 Merck Sharp & Dohme (New Zealand) Limited. Level 3, 123 Carlton Gore Road, Newmarket, Auckland. All rights reserved. ONCO TAPS MR5381 essence MSD8585 January 2018 V1

system to help fight cancer Working with your immune

system to help fight cancer Working with your immune KEYTRUDA Working with your immune system to help fight cancer www.fightcancer.co.nz CONTACT DETAILS Your Oncologist/Specialist Name Phone Phone (after hours) Your Specialist Nurse Name Phone Phone (after

More information

Important safety information to minimise the risk of immune-related adverse reactions

Important safety information to minimise the risk of immune-related adverse reactions Your Guide to KEYTRUDA (pembrolizumab) Important safety information to minimise the risk of immune-related adverse reactions Information for Patients This medicine is subject to additional monitoring.

More information

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor TECENTRIQ DISCUSSION SUPPORT What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: A type of bladder

More information

YOUR GUIDE TO TECENTRIQ (atezolizumab) non-small cell lung cancer (NSCLC)

YOUR GUIDE TO TECENTRIQ (atezolizumab) non-small cell lung cancer (NSCLC) YOUR GUIDE TO TECENTRIQ (atezolizumab) For previouslytreated advanced non-small cell lung cancer (NSCLC) ABOUT THIS BOOKLET This booklet is for people with advanced non-small cell lung cancer (NSCLC) who

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION KEYTRUDA has been issued marketing authorization with conditions for the following patients, pending the results of

More information

For the Patient: USMAVPEM

For the Patient: USMAVPEM For the Patient: USMAVPEM Other Names: Treatment of Unresectable or Metastatic Melanoma Using Pembrolizumab U = Undesignated (requires special request) SM = Skin and Melanoma AV = Advanced PEM = Pembrolizumab

More information

For the Patient: ULUAVPMB

For the Patient: ULUAVPMB For the Patient: ULUAVPMB Other Names: Treatment of Advanced Non-Small Cell Lung Cancer Using Pembrolizumab U = Undesignated (requires special approval) LU = LUng AV = AdVanced PMB = PeMBrolizumab ABOUT

More information

For the Patient: USMAVNIV

For the Patient: USMAVNIV For the Patient: USMAVNIV Other Names: Treatment of Unresectable or Metastatic Melanoma Using Nivolumab U = Undesignated (requires special approval) SM = Skin and Melanoma AV = AdVanced NIV = NIVolumab

More information

Discussing TECENTRIQ (atezolizumab) with your healthcare team

Discussing TECENTRIQ (atezolizumab) with your healthcare team Discussing TECENTRIQ (atezolizumab) with your healthcare team What is TECENTRIQ? TECENTRIQ is a prescription medicine used to treat: a type of lung cancer called non-small cell lung cancer (NSCLC). TECENTRIQ

More information

Package leaflet: Information for the patient. KEYTRUDA 25 mg/ml concentrate for solution for infusion pembrolizumab

Package leaflet: Information for the patient. KEYTRUDA 25 mg/ml concentrate for solution for infusion pembrolizumab Package leaflet: Information for the patient KEYTRUDA 25 mg/ml concentrate for solution for infusion pembrolizumab This medicine is subject to additional monitoring. This will allow quick identification

More information

For the Patient: USMAVFIPI

For the Patient: USMAVFIPI For the Patient: USMAVFIPI Other Names: First-Line Treatment of Unresectable or Metastatic Melanoma Using Ipilimumab U = Undesignated (requires special request) SM = Skin and Melanoma AV = Advanced F =

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION BAVENCIO (buh-ven-see-oh) Avelumab for Injection Solution for Intravenous Infusion Read this carefully before you start

More information

Package leaflet: Information for the patient. KEYTRUDA 50 mg powder for concentrate for solution for infusion pembrolizumab

Package leaflet: Information for the patient. KEYTRUDA 50 mg powder for concentrate for solution for infusion pembrolizumab Package leaflet: Information for the patient KEYTRUDA 50 mg powder for concentrate for solution for infusion pembrolizumab This medicine is subject to additional monitoring. This will allow quick identification

More information

What do I need to tell my doctor BEFORE I take this drug?

What do I need to tell my doctor BEFORE I take this drug? PATIENT & CAREGIVER EDUCATION Pembrolizumab Brand Names: US Keytruda Brand Names: Canada Keytruda What is this drug used for? It is used to treat cancer. What do I need to tell my doctor BEFORE I take

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION BAVENCIO (buh-ven-see-oh) Avelumab for Injection Solution for Intravenous Infusion, 20 mg/ml Professed Standard Antineoplastic

More information

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions Nivolumab Other Names: Opdivo About this Drug Nivolumab is used to treat cancer. It is given in the vein (IV). Possible Side Effects (More Common) Bone marrow depression. This is a decrease in the number

More information

What do I need to tell my doctor BEFORE I take this drug?

What do I need to tell my doctor BEFORE I take this drug? PATIENT & CAREGIVER EDUCATION Durvalumab Brand Names: US Imfinzi Brand Names: Canada Imfinzi What is this drug used for? It is used to treat cancer in the bladder or urinary tract. It is used to treat

More information

Giving appropriate patients another chance to fight OPDIVO

Giving appropriate patients another chance to fight OPDIVO For dmmr/msi-h Colorectal Cancer (CRC) All individuals depicted are models used for illustrative purposes only. Who is OPDIVO for? OPDIVO is a prescription medicine used to treat colorectal cancer (a type

More information

Get on with life, we ll see you. in 6 months. Living your life your way with MS

Get on with life, we ll see you. in 6 months. Living your life your way with MS Get on with life, we ll see you in 6 months. Living your life your way with MS If you re one of the 4000 New Zealanders affected by MS, ask your doctor or nurse if OCREVUS is right for you. Contents What

More information

MEDICATION GUIDE SUTENT

MEDICATION GUIDE SUTENT MEDICATION GUIDE SUTENT (su TENT) (sunitinib malate) capsules Read the Medication Guide that comes with SUTENT before you start taking it and each time you get a refill. There may be new information. This

More information

This leaflet answers some common questions about HERCEPTIN SC. It does not contain all the available information.

This leaflet answers some common questions about HERCEPTIN SC. It does not contain all the available information. Consumer Medicine Information HERCEPTIN SC Trastuzumab 600 mg/5 ml solution for subcutaneous injection What is in this leaflet This leaflet answers some common questions about HERCEPTIN SC. It does not

More information

(sunitinib malate) for Kidney Cancer

(sunitinib malate) for Kidney Cancer Sutent (sunitinib malate) for Kidney Cancer Sutent is a medication used to treat adult patients with kidney cancer that has been surgically removed and at high risk of recurrence, or advanced kidney cancer

More information

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use MEDICATION GUIDE BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use Read this Medication Guide before you start receiving BENLYSTA and before each treatment. There may be new information.

More information

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium) Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet

More information

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider Have a healthy discussion Use this guide to start a conversation with your healthcare provider MAKE THE CONVERSATION COUNT Here are some things you may want to reflect on and discuss with your healthcare

More information

If you have any concerns about being given this medicine, ask your doctor or pharmacist.

If you have any concerns about being given this medicine, ask your doctor or pharmacist. PRIMAXIN imipenem/cilastatin sodium 500 mg/500 mg Vial for injection What is in this leaflet This leaflet answers some common questions about PRIMAXIN. It does not contain all the available information.

More information

IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER

IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER A guide for patients and caregivers FREE TO BREATHE SUPPORT LINE (844) 835-4325 A FREE resource for lung cancer patients & caregivers About this brochure

More information

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions

More information

MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use

MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use If you are taking PegIntron with REBETOL (ribavirin) with or without an approved hepatitis C virus (HCV)

More information

Eloxatin Oxaliplatin concentrated solution for injection

Eloxatin Oxaliplatin concentrated solution for injection Eloxatin Oxaliplatin concentrated solution for injection Consumer Medicine Information Please read this leaflet before you are given this medicine. What is in this leaflet This leaflet answers some common

More information

Package leaflet: Information for the patient. Bavencio 20 mg/ml concentrate for solution for infusion avelumab

Package leaflet: Information for the patient. Bavencio 20 mg/ml concentrate for solution for infusion avelumab Package leaflet: Information for the patient Bavencio 20 mg/ml concentrate for solution for infusion avelumab This medicine is subject to additional monitoring. This will allow quick identification of

More information

All medicines have risks and benefits. Your doctor has weighed the risks of you being given Mabthera SC against the benefits expected for you.

All medicines have risks and benefits. Your doctor has weighed the risks of you being given Mabthera SC against the benefits expected for you. New Zealand Consumer Medicine Information MABTHERA SC Rituximab 1400 mg solution for subcutaneous injection for non-hodgkin s Lymphoma and 1600mg solution for subcutaneous injection for chronic lymphocytic

More information

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. CISPLATIN INJECTION CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Cisplatin Injection. It does not contain all the available information. It does

More information

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions Methotrexate About This Drug Methotrexate is used to treat cancer. This drug is given in the vein (IV). Possible Side Effects Soreness of the mouth and throat. You may have red areas, white patches, or

More information

Perjeta Contains the active ingredient pertuzumab (rch)

Perjeta Contains the active ingredient pertuzumab (rch) Perjeta Contains the active ingredient pertuzumab (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Perjeta. It does not contain all the available

More information

Summary of the Risk Management Plan (RMP) V. 1.6, July 2017 for BAVENCIO. Avelumab 200 mg/10 ml. Concentrate for Solution for Infusion

Summary of the Risk Management Plan (RMP) V. 1.6, July 2017 for BAVENCIO. Avelumab 200 mg/10 ml. Concentrate for Solution for Infusion Summary of the Risk Management Plan (RMP) V. 1.6, July 2017 for BAVENCIO Avelumab 200 mg/10 ml Concentrate for Solution for Infusion Marketing Authorisation Number 66380 Marketing Authorisation Holder:

More information

Nivolumab. Nivolumab

Nivolumab. Nivolumab Nivolumab Nivolumab This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary: for some people immunotherapy may reduce the risk of the cancer coming back, for

More information

Understanding your treatment and the side effects you may experience

Understanding your treatment and the side effects you may experience Understanding your treatment and the side effects you may experience What does treat? is a prescription medicine used in combination with YERVOY to treat a type of skin cancer called melanoma that has

More information

If you have any concerns about using this medicine, ask your doctor or pharmacist.

If you have any concerns about using this medicine, ask your doctor or pharmacist. Consumer Medicine Information Ocrevus Ocrelizumab 300 mg in 10 ml concentrate for solution for infusion What is in this leaflet Please read this leaflet carefully before you start using Ocrevus. This leaflet

More information

For the Patient: LUAVPG (Carboplatin Option)

For the Patient: LUAVPG (Carboplatin Option) For the Patient: LUAVPG (Carboplatin Option) Other Names: Treatment of Advanced n-small Cell Lung Cancer with Carboplatin and Gemcitabine LU = LUng AV = AdVanced PG = CarboPlatin, Gemcitabine ABOUT THIS

More information

Preparing for Your Immune Checkpoint Inhibitor (CPI) Treatment

Preparing for Your Immune Checkpoint Inhibitor (CPI) Treatment Preparing for Your Immune Checkpoint Inhibitor (CPI) Treatment Overview What is the immune system? What are immune checkpoint inhibitors? What are the side effects to look out for? How are side effects

More information

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine GI = GastroIntesntinal P = Pancreatic AJ = Adjuvant GEM = Gemcitabine ABOUT THIS MEDIATION What is this

More information

acting aggressive, being angry or violent yourself, or feeling hopeless)

acting aggressive, being angry or violent yourself, or feeling hopeless) MEDICATION GUIDE INTRON A (In-tron-aye) (Interferon alfa-2b, recombinant) If you are taking INTRON A with REBETOL, also read the Medication Guide for REBETOL (ribavirin) Capsules and Oral Solution. INTRON

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr SYLVANT pronounced SILL-vant siltuximab for injection Read this carefully before you start taking SYLVANT and each

More information

Is Avastin right for me? Make an informed decision about Avastin

Is Avastin right for me? Make an informed decision about Avastin Is Avastin right for me? Make an informed decision about Avastin Contents Page What is this handbook about? 2 About Avastin 3 What can Avastin do for me? 5 What else do I need to know? 7 Funded and unfunded

More information

METHYLDOPA 250 mg Film-coated Tablets

METHYLDOPA 250 mg Film-coated Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER METHYLDOPA 250 mg Film-coated Tablets METHYLDOPA This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet

Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet For many adults with type 2 diabetes Starting KAZANO gave me MORE POWER than metformin alone, with 2 medicines in 1 tablet Individual results may vary. Not actual patient. KAZANO is a prescription medicine

More information

It may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug?

It may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug? PATIENT & CAREGIVER EDUCATION Bendamustine Brand Names: US Bendeka; Treanda Brand Names: Canada Treanda What is this drug used for? It is used to treat a type of leukemia. It is used to treat a type of

More information

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read

More information

For the Patient: Rituximab injection Other names: RITUXAN

For the Patient: Rituximab injection Other names: RITUXAN For the Patient: Rituximab injection Other names: RITUXAN Rituximab (ri tux' i mab) is a drug that is used to treat some types of cancer. It is a monoclonal antibody, a type of protein designed to target

More information

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct. For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct. GI = GastroIntestinal P = Pancreas GEM = Gemcitabine ABOUT THIS MEDIATION What is this drug used for? Gemcitabine

More information

Chelation therapy for iron overload in sickle cell and thalassaemia

Chelation therapy for iron overload in sickle cell and thalassaemia Networked Services Chelation therapy for iron overload in sickle cell and thalassaemia Information for adult patients at King s College Hospital only This leaflet answers some of the questions you may

More information

BISOLVON Chesty Forte.

BISOLVON Chesty Forte. New Zealand Consumer Medicine Information BISOLVON Chesty Forte Tablets 8 mg Bromhexine hydrochloride What is in this leaflet This leaflet answers some common questions about BISOLVON Chesty Forte. It

More information

Opdivo (nivolumab) An overview of Opdivo and why it is authorised in the EU. What is Opdivo and what is it used for?

Opdivo (nivolumab) An overview of Opdivo and why it is authorised in the EU. What is Opdivo and what is it used for? EMA/852560/2018 EMEA/H/C/003985 An overview of Opdivo and why it is authorised in the EU What is Opdivo and what is it used for? Opdivo is a cancer medicine used to treat the following: melanoma, a type

More information

Your treatment with XELJANZ

Your treatment with XELJANZ Your treatment with XELJANZ (tofacitinib citrate) THIS BROCHURE HAS BEEN PRODUCED FOR PATIENTS WHO HAVE BEEN PRESCRIBED XELJANZ. BEFORE USING XELJANZ, PLEASE REVIEW THE PACKAGE LEAFLET FOR THIS MEDICINAL

More information

Herceptin. Your guide to. for HER2-positive early breast cancer. (trastuzumab)

Herceptin. Your guide to. for HER2-positive early breast cancer. (trastuzumab) Your guide to Herceptin (trastuzumab) for HER2-positive early breast cancer For more information on anything covered in this booklet talk to your specialist, doctor or nurse, or visit www.cancerinfo.co.nz

More information

IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER

IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER A guide for patients and caregivers TM Content is consistent with the Oncology Nursing Society Standards and Guidelines. The ONS Seal of Approval does not

More information

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: Amsacrine Other names: AMSA PD For the Patient: Amsacrine Other names: AMSA PD Amsacrine (AM-sa-krin) is a drug that is used to treat some types of cancer. It is a clear orange-red liquid that is injected into a vein. Tell your doctor

More information

UMN request : information to be made public Page 1

UMN request : information to be made public Page 1 Product Name KEYTRUDA Active substance Pembrolizumab MK 3475 Indication and conditions of use Keytruda for the treatment of unresectable or metastatic melanoma patients in first line therapy (or after

More information

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers Medication Information Sheet (pack li TAX ell) This document provides general information about your medication. It does not replace the advice of your health care professional. Always discuss your therapy

More information

What are some things I need to know or do while I take

What are some things I need to know or do while I take PATIENT & CAREGIVER EDUCATION Cyclophosphamide Brand Names: Canada Procytox What is this drug used for? It is used to treat cancer. It is used to treat nephrotic syndrome. It may be g iven to you for other

More information

Lamivudine, Nevirapine, and Zidovudine

Lamivudine, Nevirapine, and Zidovudine PATIENT & CAREGIVER EDUCATION Lamivudine, Nevirapine, and Zidovudine Warning Very bad and sometimes deadly liver problems have happened with this drug. The chance is highest within the first 18 weeks of

More information

WARNINGS AND PRECAUTIONS - COMBINATION OF OPDIVO AND YERVOY

WARNINGS AND PRECAUTIONS - COMBINATION OF OPDIVO AND YERVOY OPDIVO (op-dee-voh) Nivolumab (nee-vol-u-mab) Consumer Medicine Information WARNINGS AND PRECAUTIONS - COMBINATION OF OPDIVO AND YERVOY Both OPDIVO and Yervoy act on your immune system and may cause inflammation

More information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Bendamustine Other names: TREANDA For the Patient: Bendamustine Other names: TREANDA Bendamustine (ben'' da mus' teen) is a drug that is used to treat some types of cancer (lymphoma). It is a clear liquid that is injected into a vein.

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr OPDIVO is used to treat: Adults with skin cancer (advanced melanoma) who have not been treated and who have specific

More information

For the Patient: Eribulin Other names: HALAVEN

For the Patient: Eribulin Other names: HALAVEN For the Patient: Eribulin Other names: HALAVEN Eribulin (er'' i bue' lin) is a drug that is used to treat some types of cancer. It is a clear liquid that is injected into a vein. Tell your doctor if you

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen PACKAGE LEAFLET: INFORMATION FOR THE USER EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking Easofen Max Strength Tablets because it contains

More information

You should read this leaflet carefully and keep it in a safe place to refer to it later. WHAT IS OPDIVO USED FOR

You should read this leaflet carefully and keep it in a safe place to refer to it later. WHAT IS OPDIVO USED FOR (op-dee-voh) Nivolumab (nee-vol-u-mab) Consumer Medicine Information WARNINGS AND PRECAUTIONS - COMBINATION OF AND YERVOY Both and Yervoy act on your immune system and may cause inflammation in parts of

More information

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: Fludarabine injection Other names: FLUDARA For the Patient: Fludarabine injection Other names: FLUDARA Fludarabine (floo-dare-a-been) is a drug that is used to treat many types of cancer. It is a clear liquid that is injected into a vein. Tell

More information

For the Patient: Mitoxantrone Other names:

For the Patient: Mitoxantrone Other names: For the Patient: Mitoxantrone Other names: Mitoxantrone (mite-oh-zan-trone) is a drug that is used to treat many types of cancer. It is a blue liquid that is injected into a vein. Tell your doctor if you

More information

For the Patient: LUAVPEM

For the Patient: LUAVPEM For the Patient: LUAVPEM Other Names: Second-Line Treatment Of Advanced Non- Small Cell Lung Cancer (NSCLC) With Pemetrexed LU = LUng AV = AdVanced PEM = PEMetrexed ABOUT THIS MEDICATION What is this drug

More information

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide SM = Melanoma AV = Advanced TMZ = Temozolomide ABOUT THIS MEDICATION What

More information

Infliximab (Remicade ) Therapy

Infliximab (Remicade ) Therapy Patient & Family Guide Infliximab (Remicade ) Therapy 2016 www.nshealth.ca Infliximab (Remicade ) Therapy Your healthcare provider feels that treatment with infliximab may be helpful in managing your inflammatory

More information

PRIMAXIN Imipenem/Cilastatin sodium

PRIMAXIN Imipenem/Cilastatin sodium PRIMAXIN Imipenem/Cilastatin sodium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PRIMAXIN. It does not contain all the available information. It

More information

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Dexamethasone Other Names: Decadron About This Drug Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Possible Side Effects (More Common) Increased

More information

Do not g ive this drug if your child has an infection or any inflammation.

Do not g ive this drug if your child has an infection or any inflammation. PATIENT & CAREGIVER EDUCATION Tisagenlecleucel Brand Names: US Kymriah Warning A very bad health problem called cytokine release syndrome (CRS) has happened with this drug. Sometimes, this has been life-threatening

More information

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: Trastuzumab emtansine Other names: KADCYLA For the Patient: Trastuzumab emtansine Other names: KADCYLA Trastuzumab emtansine (tras tooz' ue mab em tan' seen) is a drug that is used to treat some types of cancer. Trastuzumab emtansine is a clear

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET PROSTATIN (OCTREOTIDE ACETATE INJECTION 10mcg, 50mcg) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again.

More information

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Ponatinib Other names: ICLUSIG For the Patient: Other names: ICLUSIG (poe na' ti nib) is a drug that is used to treat some types of cancer. It is a tablet that you take by mouth. The tablet contains lactose. Tell your doctor if you

More information

IMIPENEM+CILASTATIN RBX

IMIPENEM+CILASTATIN RBX IMIPENEM+CILASTATIN RBX imipenem/cilastatin sodium 500 mg/500 mg Powder for Solution for Infusion What is in this leaflet This leaflet answers some common questions about IMIPENEM+CILASTATIN RBX. It does

More information

Inlyta (axitinib) for Kidney Cancer

Inlyta (axitinib) for Kidney Cancer Inlyta (axitinib) for Kidney Cancer Inlyta is a medication used to treat advanced kidney cancer in adults when one prior drug treatment for this disease has not worked Dosage: 5mg taken twice a day How

More information

Talking about your treatment. A guide to the conversations you may have before starting LEMTRADA

Talking about your treatment. A guide to the conversations you may have before starting LEMTRADA Talking about your treatment A guide to the conversations you may have before starting LEMTRADA INTRODUCTION HEALTHCARE TEAM CARE TEAM COWORKERS Please see Important Safety Information on pages 6-7 and

More information

Amlodipine and Celecoxib

Amlodipine and Celecoxib PATIENT & CAREGIVER EDUCATION Amlodipine and Celecoxib Warning This drug may raise the chance of heart and blood vessel side effects like heart attack and stroke. If these happen, they can be deadly. The

More information

Personal Calendar Tracker

Personal Calendar Tracker Personal Calendar Tracker The Personal Calendar Tracker was created as a companion to the Patient and Family Reference Handbook, which was developed for people living with kidney cancer and their families.

More information

For the Patient: Lenalidomide Other names: REVLIMID

For the Patient: Lenalidomide Other names: REVLIMID For the Patient: Lenalidomide Other names: REVLIMID Lenalidomide (len a lid' oh mide) is a drug that is used to treat several types of cancer. It is a capsule that you take by mouth. Tell your doctor if

More information

Gemcitabine and Cisplatin

Gemcitabine and Cisplatin PATIENT EDUCATION patienteducation.osumc.edu What is Gemcitabine (jem-site-a been)? Gemcitabine is a chemotherapy medicine known as an anti-metabolite. Another name for this drug is Gemzar. This drug is

More information

Intravenous anti-cancer treatment

Intravenous anti-cancer treatment Intravenous anti-cancer treatment Information for patients Chemotherapy Name Hospital No Your consultant is Anti-cancer treatment is the term used to describe medicines used to treat cancer including chemotherapy.

More information

A medicine to block the amount of acid produced in the stomach (H2 blocker): about 10 hours before about 2 hours after

A medicine to block the amount of acid produced in the stomach (H2 blocker): about 10 hours before about 2 hours after TRACKING JOURNAL YOUR TRACKING JOURNAL Throughout your treatment with TASIGNA (nilotinib), your doctor will prescribe regular tests to see if your treatment is working. It s important to keep up with your

More information

Consumer Medicine Information March 2009

Consumer Medicine Information March 2009 March 2009 50 (oxaliplatin 50mg power for injection vial) 100 (oxaliplatin 100mg power for injection vial) What is in this leaflet? This leaflet answers some common questions about Powder for injection.

More information

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions Sunitinib Other Names: Sutent About This Drug Sunitnib is used to treat cancer. It is given orally (by mouth). Possible Side Effects Headache Tiredness and weakness Soreness of the mouth and throat. You

More information

GARDASIL 9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Consumer Medicine Information

GARDASIL 9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Consumer Medicine Information GARDASIL 9 [Human Papillomavirus 9-valent Vaccine, Recombinant] Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available

More information

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS HCP Prescribing Information Date/Version January 2015 Version 2 Page: 1 of 5 I. ALL CLAIMS: HEALTH CARE PROFESSIONALS Indications and Usage Saxenda (liraglutide [rdna origin] injection) is indicated as

More information

Sorafenib (Nexavar ) For thyroid carcinoma

Sorafenib (Nexavar ) For thyroid carcinoma Sorafenib (Nexavar ) for thyroid carcinoma Sorafenib (Nexavar ) For thyroid carcinoma This leaflet is offered as a guide to you and your family. Sorafenib is a type of anti-cancer treatment called a targeted

More information

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET PROPOSED PATIENT INFORMATION LEAFLET FOR PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET SCHEDULING STATUS S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PHARMA DYNAMICS CLOPIDOGREL

More information

VELCADE Powder for Injection Bortezomib3.5 mg and 1 mg

VELCADE Powder for Injection Bortezomib3.5 mg and 1 mg VELCADE Powder for Injection Bortezomib3.5 mg and 1 mg Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about VELCADE Powder for Injection. It does not contain

More information

If you have any concerns about being given this vaccine, ask your doctor or pharmacist.

If you have any concerns about being given this vaccine, ask your doctor or pharmacist. PNEUMOVAX 23 Pneumococcal Vaccine Single Dose Vial/Pre-filled Syringe What is in this leaflet This leaflet answers some common questions about PNEUMOVAX 23. It does not contain all the available information.

More information